These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 1712626
1. Failure of salvage treatment in metastatic testicular teratoma. Whillis D, Coleman RE, Cornbleet MA, Howard GC. Clin Oncol (R Coll Radiol); 1991 May; 3(3):141-6. PubMed ID: 1712626 [Abstract] [Full Text] [Related]
2. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. Fosså SD, Aass N, Ous S, Høie J, Stenwig AE, Lien HH, Paus E, Kaalhus O. J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726 [Abstract] [Full Text] [Related]
3. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer. Pizzocaro G, Salvioni R, Pasi M, Zanoni F, Milani A, Pilotti S, Monfardini S. Cancer; 1985 Jul 15; 56(2):249-55. PubMed ID: 2408728 [Abstract] [Full Text] [Related]
4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature. Porcaro AB, Antoniolli SZ, Maffei N, Beltrami P, Bassetto MA, Curti P. Arch Ital Urol Androl; 2002 Jun 15; 74(2):81-5. PubMed ID: 12161942 [Abstract] [Full Text] [Related]
5. Adequacy of chemotherapy prior to cytoreductive surgery in testicular carcinoma. Kennedy BJ, Torkelson JL, Fraley EE. Am J Clin Oncol; 1996 Dec 15; 19(6):541-5. PubMed ID: 8931667 [Abstract] [Full Text] [Related]
10. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. Gelderman WA, Schraffordt Koops H, Sleijfer DT, Oosterhuis JW, Van der Heide JN, Mulder NH, Marrink J, De Bruyn HW, Oldhoff J. J Surg Oncol; 1988 Aug 15; 38(4):227-32. PubMed ID: 2457771 [Abstract] [Full Text] [Related]
14. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours. Gerl A, Clemm C, Schmeller N, Dienemann H, Weiss M, Kriegmair M, Löhrs U, Wilmanns W. Br J Cancer; 1994 Nov 15; 70(5):960-5. PubMed ID: 7524606 [Abstract] [Full Text] [Related]
15. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer. Pizzocaro G, Pasi M, Salvioni R, Zanoni F, Milani A, Piva L. Cancer; 1985 Nov 15; 56(10):2399-403. PubMed ID: 2412681 [Abstract] [Full Text] [Related]
16. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Dearnaley DP, Horwich A, A'Hern R, Nicholls J, Jay G, Hendry WF, Peckham MJ. Eur J Cancer; 1991 Nov 15; 27(6):684-91. PubMed ID: 1712606 [Abstract] [Full Text] [Related]
17. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT). de Bono JS, Paul J, Simpson A, Anthoney A, Kirk D, Underwood M, Graham J, Kaye SB. Br J Cancer; 2000 Aug 15; 83(4):426-30. PubMed ID: 10945485 [Abstract] [Full Text] [Related]